Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Receivables (2016 - 2025)

Healthy Extracts (HYEX) has 11 years of Receivables data on record, last reported at $31264.0 in Q3 2025.

  • For Q3 2025, Receivables rose 58.17% year-over-year to $31264.0; the TTM value through Sep 2025 reached $31264.0, up 58.17%, while the annual FY2024 figure was $11004.0, 63.85% down from the prior year.
  • Receivables reached $31264.0 in Q3 2025 per HYEX's latest filing, up from $3980.0 in the prior quarter.
  • Across five years, Receivables topped out at $135398.0 in Q1 2023 and bottomed at $3980.0 in Q2 2025.
  • Average Receivables over 5 years is $70440.7, with a median of $83585.0 recorded in 2021.
  • Peak YoY movement for Receivables: surged 904.52% in 2021, then crashed 95.61% in 2025.
  • A 5-year view of Receivables shows it stood at $133340.0 in 2021, then decreased by 20.66% to $105794.0 in 2022, then tumbled by 71.23% to $30440.0 in 2023, then plummeted by 63.85% to $11004.0 in 2024, then skyrocketed by 184.11% to $31264.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $31264.0 in Q3 2025, $3980.0 in Q2 2025, and $69981.0 in Q1 2025.